4. Benefit/risk balance of nanoparticle-based drugs
As mentioned in the
2
section of this article, a drug can be formulated in a nanoparticle (encapsulation) or be the nanoparticle itself. For example, the aim is to:
You do not have access to this resource.
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed?
Log in!
Ongoing reading
Benefit/risk balance of nanoparticle-based drugs
Bibliography
-
(1) - DU (B.), YU (M.), ZHENG (J.) -
Transport and interactions of nanoparticles in the kidneys.
-
Nature Reviews Materials, 3(10) : p. 358-74 (2018).
-
(2) - COUVREUR (P.), FATTAL (E.), ANDREMONT (A.) -
Liposomes and...
You do not have access to this resource.
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed?
Log in!